Medical Imaging Biochemical Markers Clinical Research Centers
About Synarc Synarc Experts News & Events
 
     
     
     
   
     
     
  
 
     
 

Gabriele von Ingersleben, M.D., Ph.D.
Senior Director, Radiology Services

Gabriele von Ingersleben, M.D., Ph.D., is a board certified Radiologist with global clinical research experience. At Synarc, she is the Senior Director of Reading Services and supervises the Image Reading Group to provide effective and efficient reading services.

Prior to Synarc, Dr. von Ingersleben was the Acting Instructor in the Department of Radiology at the University of Washington, Medical Center in Seattle, WA. She was also the Assistant Professor Department of Radiology Auguste-Viktoria-Hospital and Moabit Hospital in Berlin, Germany for six years. While at Auguste-Viktoria-Hospital and Moabit Hospital, she also focused on treating cancer patients with radiation and chemotherapy and was also involved in interpretation of nuclear medicine images.

Dr. von Ingersleben received her medical degree from Medical School at the Free University of Berlin and completed her residency at the Radiology Department of the Auguste-Viktoria-Hospital in Berlin, Germany. She received her Ph.D. from Free University of Berlin in Berlin, Germany where her dissertation was on relationship between body mass and risk factors for diseases of the heart and circulatory system. She was a fellow at the Department of Radiology, University of Washington, Medical Center, Seattle, WA. Dr. von Ingersleben has written numerous scientific publications and continues to lecture on imaging and clinical research techniques around the world.  

Dr. Gabriele von Ingersleben can be reached by phone at +1.415.817.8971 and email at Gabriele.vonIngersleben@Synarc.com.
 
 

Scientific Publications:

Newitt DC, Majumdar S, van Rietbergen B, von Ingersleben G, Harris St, Genant HK, Chesnut C, Garnero P, MacDonald B. In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius. Osteoporosis Int. 2002, 13 (1): 6 -17

Gardner JC, von Ingersleben G, Heyano SL, Chesnut CH III. An interactive tutorial - based training technique for vertebral morphometry. Osteoporosis Int 2001; 12: 63 - 70

Gardner JC, Yaffe LG, Johansen JM, von Ingersleben G, Chesnut CH III. Problems with six point vertebral morphometry.SPIE (The International Society for Optical Engineering) Medical Image Processing 1998; 3338(1) 107-117

von Ingersleben G, Schmiedl UP, Dong PC, Nelson JA, Starr F, Ho R. Intestinal absorption of ManganeseMesoporphyrin in a small bowel sac system. Effect of oleic acid on absorption rate. Acad Radiol 1997; 4:355-360

von Ingersleben G, Schmiedl UP, Hatsukami TS, Nelson JA, Subramaniam DS, Ferguson MS, Yuan C. Characterization of atherosclerotic plaques at the carotid bifurcation: Correlation of high resolution MR with histology; a preliminary study. RadioGraphics 1997; 17:1417-1423

Gardner JC, Heyano SL, von Ingersleben G, Chesnut C III. A semi-automated computerized system for fracture assessment of spinal x-ray films. Image Processing, ed. M.H. Loew and K.M. Hanson, SPIE (The International Society for Optical Engineering) Proceedings 1996; 2710: 996-1008

Freeny PC, Gardner JC, von Ingersleben G, Heyano SL, Nghiem HV, Winter TC. Hepatic helical CT: Effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Radiology 1995; 197(1): 89-93

Heidemann E, Steinke B, Hartlapp J, Schumacher K, Possinger K, Kunz S, Neeser E, von Ingersleben G, Hossfeld D, Caffier H, Souchon R, Waldmann R, Blümer E, Clark J. Prognostic subgroups: the key factor for treatment outcome in metastatic breast cancer. Onkologie 16 1993; 344-353

Heidemann E, Steinke B, Hartlapp J, Schumacher K, Possinger K, Kunz S, Neeser E, von Ingersleben G, Hossfeld D, Caffier H, Souchon R, Waldmann R, Blümer E, Clark J, Schrueffer, R. Metastasierendes Mammakarzinom - Prognostische Faktoren bestimmen den Verlauf stärker als die Wahl des Therapieschemas (transl.: Metastatic breast cancer - prognostic factors determine the progress stronger than the choice of therapeutic scheme). In: Aktuelle Onkologie 66, W. Zuckschwerdt Verlag München, Bern, Wien, New York 1992; 71-80

Heidemann E, Steinke B, Hartlapp J, Schumacher K, Possinger K, Kunz S, Neeser E, von Ingersleben G, Hossfeld D, Waldmann R. Randomized clinical trial comparing Mitoxatrone with Epirubicin and with Doxorubicin, each combined with Cyclophosphamide in the first-line treatment of patients with metastatic breast cancer. Onkologie 13 1990; 1: 24-27

von Ingersleben G, Souchon R, Fitzner R. Serum Neopterin levels in lung and breast cancer patients undergoing radiotherapy and/or chemotherapy. Intern. J. of Biological Markers 1988; 3 (2): 135-139

von Ingersleben G, Souchon R, Brandt U, Fitzner R. CA 15-3 in comparison with CEA follow-up on therapy control of breast-carcinoma - new aspects. In: New tumor markers and their monoclonal antibodies. In: Hrsg. Klapdor, R.Thiema-Verlag Stuttgart 1987; 113-117

Souchon R, von Ingersleben G, Fitzner R, Plass S. Die Bedeutung des CA 15-3 Tumormarkers für die Therapiekontrolle des metastasierten Mamma-Karzinoms (transl.: The significance of the tumor marker CA 15-3 for therapy control of breast carcinoma). In: Klinische Relevanz neuer monoklonaler Antikörper. Hrsg. von Greten und Klapdor; Thieme-Verlag Stuttgart 1986; 234-23

Souchon R, von Ingersleben G, Bürmann E, Fitzner R. Klinische Verlaufskontrolle bei Patienten mit fortgeschrittenem Mamma-, Kolon- oder Bronchial-Karzinom durch Bestimmung des CEA und CA 19-9 mit monoklonalen Antiköpern - Ein Rückblick nach 2 Jahren Anwendung von Tumormarkern (transl.: Clinical follow-up of patients with advanced breast , colon or lung carcinoma by determination of CEA and CA 19-9 with monoclonal antibodies - a retrospect after 2 years application of tumor markers). In: Tumormarker, Hrsg. von Wuest, G. Steinkopff-Verlag Darmstadt 1986; 200-201

Souchon R, von Ingersleben G, Souchon M-F. Bedeutung und Anwendung von Tumormarkern (transl.: Significance and application of tumor markers). mta praxis 1985; 31: 645-647

von Ingersleben, Gabriele. Körpermaße und Risikofaktoren für Krankheiten des Herz-/Kreislaufsystems (transl.: Relationship between body mass and risk factors for diseases of the heart and circulatory system). Soz.Ep-Hefte 3/1984 (Institut für Sozialmedizin und Epidemiologie des Bundesgesundheitsamtes) 1984 Berlin, Germany
Site Map     Legal Statement     © Copyright 2008 Synarc Inc.